GlassScriptPhysician profile
Robin Leigh Riddle
NPI 1942727946
$1,105.39
in general payments reported to CMS, 2019-2025
11 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $251 · 2023: $248 · 2024: $238 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $572.75 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Redhill Biopharma INC. | $191.41 | 2022-2023 | Talicia |
| Idorsia Pharmaceuticals US INC | $161.14 | 2023 | Quviviq |
| Lilly USA, LLC | $62.24 | 2022-2025 | Zepbound |
| Acella Pharmaceuticals, LLC | $22.50 | 2025 | NP Thyroid 60 |
| Pfizer INC. | $19.57 | 2024 | |
| Corcept Therapeutics | $18.06 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $16.51 | 2021 | |
| Clarus Therapeutics INC. | $15.00 | 2021 | |
| Currax Pharmaceuticals LLC | $14.03 | 2024 | Contrave |
| Mannkind Corporation | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.